Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation
- PMID: 8702007
- PMCID: PMC1865304
Expression of perforin in nasal lymphoma. Additional evidence of its natural killer cell derivation
Abstract
Eight patients with nasal lymphoma in whom fresh-frozen tissues were available were studied to elucidate the nature of the lymphoma cells. Two cases were diagnosed as diffuse, large cell lymphoma, and the remaining six cases as diffuse, mixed cell types. Immunohistochemical studies revealed that all of the cases were positive for perforin, which is a specific marker for cytotoxic T or natural killer (NK) cells. As all of the cases were CD8 negative, the perforin-positive finding further confirmed the concept that nasal lymphoma is a distinct neoplastic entity derived from NK or NK-related cells. Light microscopic immunohistochemical studies revealed that these nasal lymphoma cases could be classified into Leu19(CD56)+Leu4(CD3)+ (two cases) and Leu19(CD56)+Leu4(CD3)- (six cases) types according to the phenotypes of the proliferating cells. However, simultaneous staining for perforin and Leu4 (CD3) using immunoelectron microscopy on the Leu19+Leu4+ cases showed that the perforin-positive cells were different from the Leu4-positive cells. This finding suggests that the Leu4-positive cells are not neoplastic NK cells but reactive T cells. Six cases were positive for EBER-1 by in situ hybridization analysis. This finding reconfirms the previous studies that Epstein-Barr virus plays a significant role in the pathogenesis of nasal lymphoma.
Similar articles
-
Perforin and granzyme expression in cytotoxic T-cell lymphomas.Mod Pathol. 1998 Apr;11(4):313-23. Mod Pathol. 1998. PMID: 9578080
-
Primary lymphoma arising in the nasal cavity among Japanese.Histopathology. 2005 Nov;47(5):523-32. doi: 10.1111/j.1365-2559.2005.02265.x. Histopathology. 2005. PMID: 16242001
-
Nasal T/natural killer (NK)-cell lymphomas are derived from Epstein-Barr virus-infected cytotoxic lymphocytes of both NK- and T-cell lineage.Int J Cancer. 1997 Nov 4;73(3):332-8. doi: 10.1002/(sici)1097-0215(19971104)73:3<332::aid-ijc5>3.0.co;2-0. Int J Cancer. 1997. PMID: 9359478
-
Nasopharyngeal/nasal type T/NK lymphomas: analysis of 14 cases and review of the literature.Tumori. 2003 May-Jun;89(3):278-84. doi: 10.1177/030089160308900309. Tumori. 2003. PMID: 12908783 Review.
-
Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm.Blood. 1997 Jun 15;89(12):4501-13. Blood. 1997. PMID: 9192774 Review.
Cited by
-
Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.Exp Mol Med. 2015 Jan 23;47(1):e133. doi: 10.1038/emm.2014.105. Exp Mol Med. 2015. PMID: 25613730 Free PMC article. Review.
-
Extranodal NK-/T-cell lymphoma, nasal type: what advances have been made in the last decade?Front Oncol. 2023 Jul 17;13:1175545. doi: 10.3389/fonc.2023.1175545. eCollection 2023. Front Oncol. 2023. PMID: 37529691 Free PMC article. Review.
-
TIA-1 expression in lymphoid neoplasms. Identification of subsets with cytotoxic T lymphocyte or natural killer cell differentiation.Am J Pathol. 1997 Jun;150(6):1893-900. Am J Pathol. 1997. PMID: 9176382 Free PMC article.
-
Special techniques in diagnostic electron microscopy.Hum Pathol. 1998 Dec;29(12):1339-46. doi: 10.1016/s0046-8177(98)90001-6. Hum Pathol. 1998. PMID: 9865818 Free PMC article. Review.
-
NK/T-cell lymphomas: pathobiology, prognosis and treatment paradigm.Curr Oncol Rep. 2012 Oct;14(5):395-402. doi: 10.1007/s11912-012-0245-9. Curr Oncol Rep. 2012. PMID: 22639106 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials